The Clorox Company trades at a 17x forward P/E, 20% below the S&P 500, but I see fair value closer to $80 per share. Learn ...
This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback